CN1311860C - Oral medicine for treating disease of digestive system such as gastric ulcer - Google Patents

Oral medicine for treating disease of digestive system such as gastric ulcer Download PDF

Info

Publication number
CN1311860C
CN1311860C CNB031013287A CN03101328A CN1311860C CN 1311860 C CN1311860 C CN 1311860C CN B031013287 A CNB031013287 A CN B031013287A CN 03101328 A CN03101328 A CN 03101328A CN 1311860 C CN1311860 C CN 1311860C
Authority
CN
China
Prior art keywords
digestive system
gastric ulcer
oral medicine
acute
chronic gastritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031013287A
Other languages
Chinese (zh)
Other versions
CN1437979A (en
Inventor
孙洪发
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qinghai Pulante Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031013287A priority Critical patent/CN1311860C/en
Publication of CN1437979A publication Critical patent/CN1437979A/en
Application granted granted Critical
Publication of CN1311860C publication Critical patent/CN1311860C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an oral medicine for treating digestive system diseases, such as gastric ulcer, acute and chronic gastritis, etc., which is a preparation medicine prepared from traditional Chinese medicines and tibetan medicines, such as purple bergenia, Chinese ginger, etc. by scientific refining technology. The oral medicine of the present invention has the effects of soothing the liver, regulating the circulation of qi, regulating the stomach and spleen, relieving inflammation, alleviating pain, etc. The oral medicine of the present invention is suitable for digestive system diseases, such as gastric ulcer, acute and chronic gastritis, gastralgia, hyperacidity, gastrectasia, etc.

Description

A kind of oral drugs for the treatment of the gastric ulcer digestive system disease
Technical field
The present invention relates to a kind of medicine for the treatment of digestive system disease, in particular for treatment gastric ulcer, acute and chronic gastritis, in the digestive system disease such as stomachache, gastric acid, flatulence, Tibetan medicine new drug oral formulations one compound recipe and the capsule for treating gastropathy made:
Background technology
Gastric ulcer, acute and chronic gastritis, digestive system disease such as stomachache, gastric acid, flatulence are common clinicals, frequently-occurring disease, modal symptom are stomachache, flatulence, gastric acid etc.The oral drugs of treatment gastric ulcer generally adopt antiinflammatory, analgesia, protection gastric mucosa at present; regulate methods such as gastric juice acid-base value; great majority are a kind of therapeutic modalities of curing the symptoms, not the disease; can really suppress helicobacter pylori; repair gastric mucosa, reduce total acidity gastric juice, promote ulcer healing; the middle Tibetan medicine oral drugs of determined curative effect, few in number especially.
Summary of the invention
The purpose of this invention is to provide a kind of treatment gastric ulcer, the active drug of digestive system disease such as acute and chronic gastritis.
The objective of the invention is to realize by following measure: a kind of oral drugs for the treatment of digestive system disease such as gastric ulcer, the raw material weight that is used as medicine is: Rhizoma Seu Herba Bergeniae 100-1000g, Rhizoma Alpiniae Officinarum 10-300g.
The present invention treats gastric ulcer, the oral drugs of digestive system disease such as acute and chronic gastritis, and the weight of its raw material that is used as medicine is preferably: Rhizoma Seu Herba Bergeniae 950g, Rhizoma Alpiniae Officinarum 100g.
Described oral drugs preparation technology: get Rhizoma Seu Herba Bergeniae and be ground into coarse powder, with 50% alcohol reflux 4 times, each 2 hours, merge extractive liquid,, vacuum concentration become relative density 1.15-1.20 (60 ℃) extractum, vacuum drying (<80 ℃), pulverize, get the Rhizoma Seu Herba Bergeniae extract powder.Other gets Rhizoma Alpiniae Officinarum, cleans, and drying, micronizing with above-mentioned extract powder mixing, add appropriate amount of auxiliary materials to less than 200 orders, and be encapsulated, promptly.
Specific implementation method
The new drug oral formulations that adopts the present invention to make, analgesia, antiinflammatory effect are remarkable, can effectively suppress helicobacter pylori, reduce total acidity gastric juice, promote ulcer healing, are a kind of medicines of comparatively ideal efficient, oral, treatment digestive system disease.
Rhizoma Seu Herba Bergeniae (rein in loud, high-pitched sound all, Tibetan language transliteration): be a kind of national conventional crude drugs, contain chemical compounds such as Bergeninum, arbutin, have strengthening by means of tonics, anti-inflammatory analgetic, hemostasis is promoted the production of body fluid, and helps digestion to build spleen detoxifcation, cough-relieving, convergence, effect such as bring down a fever.Be used for cough clinically, headache, stomachache, dysentery, pneumonia, multiple treatment of diseases such as diarrhoea.Single using or the prescription use.
Rhizoma Alpiniae Officinarum: rhizome contains flavone compound Rhizoma Alpiniae Officinarum water decoctions such as quintessence oil, galangin, galangol, kaempferide in vitro all has inhibitory action to anthrax bacillus, Hemolytic streptococcus, diphtheria corynebacterium, Diplococcus pneumoniae, staphylococcus aureus, tubercule bacillus.

Claims (2)

1, a kind of treatment gastric ulcer, the oral drugs of acute and chronic gastritis digestive system disease is characterized in that people's medicine raw material weight is: Rhizoma Seu Herba Bergeniae 100-1000g, Rhizoma Alpiniae Officinarum 10-300g.
2, a kind of treatment gastric ulcer according to claim 1, the oral drugs of acute and chronic gastritis digestive system disease is characterized in that its raw material weight is: Rhizoma Seu Herba Bergeniae 950g, Rhizoma Alpiniae Officinarum 100g.
CNB031013287A 2003-01-04 2003-01-04 Oral medicine for treating disease of digestive system such as gastric ulcer Expired - Fee Related CN1311860C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031013287A CN1311860C (en) 2003-01-04 2003-01-04 Oral medicine for treating disease of digestive system such as gastric ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031013287A CN1311860C (en) 2003-01-04 2003-01-04 Oral medicine for treating disease of digestive system such as gastric ulcer

Publications (2)

Publication Number Publication Date
CN1437979A CN1437979A (en) 2003-08-27
CN1311860C true CN1311860C (en) 2007-04-25

Family

ID=27673827

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031013287A Expired - Fee Related CN1311860C (en) 2003-01-04 2003-01-04 Oral medicine for treating disease of digestive system such as gastric ulcer

Country Status (1)

Country Link
CN (1) CN1311860C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358575C (en) * 2005-08-19 2008-01-02 深圳市东方泰格生物医药有限公司 Medicine for treating gastric cavity pains, process for preparing the same and application thereof
CN103893732B (en) * 2014-04-22 2016-09-07 青海省通天河藏药制药有限责任公司 A kind of Tibetan medicine treating chronic gastritis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
仲景胃灵胶囊抗胃溃疡作用研究 叶木荣、李锐、廖雪珍、廖惠芳、周玖瑶,中成药,第24卷第9期 2002 *
岩白菜素抗大鼠实验性胃溃疡的研究 张正仙,张肇玖,赵永娜,中草药,第30卷 1999 *
急慢性胃炎的食疗 吴吴,药膳食疗研究,第2期 1999 *
急慢性胃炎的食疗 吴吴,药膳食疗研究,第2期 1999;岩白菜素抗大鼠实验性胃溃疡的研究 张正仙,张肇玖,赵永娜,中草药,第30卷 1999;仲景胃灵胶囊抗胃溃疡作用研究 叶木荣、李锐、廖雪珍、廖惠芳、周玖瑶,中成药,第24卷第9期 2002 *

Also Published As

Publication number Publication date
CN1437979A (en) 2003-08-27

Similar Documents

Publication Publication Date Title
CN1562151A (en) Medicinal formulation for treating upper respiratory track infection and its design method
CN102526355A (en) Chinese medicinal compound preparation for resisting virus and treating flu and cold
CN103202880B (en) Medicine for treating allergic rhinitis and method for preparing medicine
CN101708278B (en) Medicament for treating oral plane lichen and preparation method thereof
CN110974887A (en) Traditional Chinese medicine composition for resisting lung cancer
CN101229290A (en) Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof
CN111297965A (en) Traditional Chinese medicine composition for treating chronic nephritis
CN101972391A (en) Medicinal composition used for treating swine mastitis and preparation method thereof
CN1311860C (en) Oral medicine for treating disease of digestive system such as gastric ulcer
CN111840456A (en) Chinese medicinal composition for treating respiratory system diseases
CN101249184B (en) Medicine for treating osteoproliferation as well as its preparation method
CN103705578B (en) There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof
CN1404854A (en) Medicine for treating nosal inflammation
CN100402073C (en) Medicine for treating disease caused by heat toxin
CN101073657B (en) 'Traditional Chinese-medicinal preparation for treating oral ulcers
CN106214804B (en) Traditional Chinese medicine composition for removing acne and application thereof
CN101972313A (en) Medicament for treating rhinitis
CN1242800C (en) Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis
CN104162063A (en) Traditional Chinese medicine compound preparation for treating hyperuricemia and production method thereof
CN1324648A (en) Quick-acting gastropathy treating medicine powder and its prepn.
CN102626491B (en) Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion
CN101670046A (en) Chinese medicinal composition for gastritis and esophagitis and preparation process thereof
CN1270754C (en) Gastropathy treating medicine and its preparation
CN101011512A (en) Medicine for treating digestive tract tumour and its preparing process
CN100394967C (en) Chinese medicine composition for treating wrinary tract disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QINGHAI PULANTE MEDICINE CO., LTD.

Free format text: FORMER OWNER: SUN HONGFA

Effective date: 20090403

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20090403

Address after: No. 2 Dong Xin Road, Xining economic and Technological Development Zone

Patentee after: Qinghai Pulante Pharmaceutical Co., Ltd.

Address before: No. 2, Dongxin Road, Xining, Qinghai

Patentee before: Sun Hongfa

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070425

Termination date: 20130104

CF01 Termination of patent right due to non-payment of annual fee